Who's joining — and leaving — CG Oncology.
Leadership hires, departures, and promotions from SEC 8-K filings — dated, named, and cited. The record shows the moves; a brief shows what they mean for your offer.
Have an offer from CG Oncology? Check it against these numbers — free.
Check my offer →Where its leaders come from
Neurogastrx, Inc. ×2Immunome, Inc. ×1
Recent leadership moves on the record
- Ambaw Bellete— departure: President & Chief Operating Officer2026-06-30filing
- Jim DeTore— hire: Chief Financial Officer (from Neurogastrx, Inc.)2026-04-13filing
- Robert Lapetina— departure: interim principal financial and accounting officer2025-11-30filing
- Christina Rossi— hire: Class II director2025-11-24filing
- Simone Song— departure: member of the Audit Committee and chair of the Compensation Committee2025-11-22filing
- Jim DeTore— hire: principal financial and accounting officer (from Neurogastrx, Inc.)2025-11-17filing
- Corleen Roche— departure: Chief Financial Officer2025-08-05filing
- Robert Lapetina— hire: principal financial and accounting officer (from Immunome, Inc.)2025-08-05filing
- Ambaw Bellete— hire: President and Chief Operating Officer2025-01-09filing
- Arthur Kuan— hire: Chief Executive Officer2025-01-09filing
- Vijay Kasturi, M.D.— hire: Chief Medical Officer2025-01-09filing
- Corleen Roche— hire: Chief Financial Officer2025-01-09filing
Have an offer from CG Oncology?
See exactly where your number sits in the certified band — free. Or get the full brief: company health, role risk, and the negotiation playbook, every claim cited. Ready in about ten minutes · seven-day refund.